A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone
Open Access
- 3 February 2004
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 57 (5), 616-621
- https://doi.org/10.1111/j.0306-5251.2003.02055.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Anecdotes as evidenceBMJ, 2003
- Overview and meta-analysis of randomised trials of amiodarone in chronic heart failureInternational Journal of Cardiology, 1998
- Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trialsThe Lancet, 1997
- Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIATThe Lancet, 1997
- Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIATThe Lancet, 1997
- Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of MedicinesBritish Journal of Clinical Pharmacology, 1996
- Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular ArrhythmiaThe New England Journal of Medicine, 1995
- Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot studyJournal of Invasive Cardiology, 1992
- Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopyAmerican Heart Journal, 1991
- Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.Journal of the American College of Cardiology, 1991